Beutler F (1984) Glucose-6-phosphate dehydrogenase (G-6-PD) and 6- phosphogluconate dehydrogenase (6-PGD). In: Red cell metabolism. Grune and
Stratton, Orlando, FL, pp 68 –71
Bowen DM, Spillane JA, Curzon G, Meier-Ruge W, White P, Goodhardt MJ, Iwangoff
P, Davison AN (1979) Accelerated ageing or selective neuronal loss as an important
cause of dementia? Lancet i: 11–14
Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta
Neuropathol 82: 239–259
Cohen G (1988) Oxygen radicals and Parkinson's disease. In: Halliwell B (ed) Oxygen
radicals and tissue injury. FASEB, Bethesda, MA, pp 130–135
Cotgreave IA, Moldéus P, Orrenius S (1988) Host biochemical defense mechanisms
against prooxidants. Ann Rev Pharmacol Toxicol 28: 189–212
Cribb AE, Leeder JS, Spielberg SP (1989) Use of a microplate reader in an assay of
glutathione reductase using 5,5'-dithiobis(2-nitrobenzoic acid). Anal Biochem 183:
195–196
Crapper McLachlan DR, Dalton AJ, Kruck TPA, Bell MY, Smith WL, Kalow W,
Andrews DF (1991) Intramuscular desferrioxamine in patients with Alzheimer's
disease. Lancet 337: 1304–1308
Davis JB (1996) Oxidative mechanisms in â-amyloid toxicity. Neurodegeneration 5: 441–
444
DeKosky ST, Harbaugh RE, Schmitt FA, Bakay RAE, Chui HC, Knopman DS, Reeder
TM, Shetter AG, Senter HJ, Markesbery WR, Intraventrical Bethanecol Study
Group (1992) Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Ann Neurol 32: 625–
632
Flohe L, Gunzler WA (1984) Assays of glutathione peroxidase. Meth Enzymol 105: 114–
121
Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state: a practical method for
grading the cognitive state of patients for the clinician. J Psychiat Res 34: 189–198
Francis PT, Palmer AM, Sims NR, Bowen DM, Davison AN, Esiri MM, Neary D,
Snowden JS, Wilcock GK (1985) Neurochemical studies of early-onset Alzheimer's
disease: possible influence on treatment. N Engl J Med 313: 7–11
Francis PT, Bowen DM, Lowe SL, Neary D, Mann DMA, Snowden JS (1987) Somatostatin content and release measured in cerebral biopsies from demented patients. J
Neurol Sci 78: 1–16
Gotz ME, Freyberger A, Hauer E, Burger R, Sofic E, Gsell W, Heckers S, Jellinger K,
Hebenstreit G, Frölich L, Beckmann H, Riederer P (1992) Susceptibility of brains
from patients with Alzheimer's disease to oxygen-stimulated lipid peroxidation and
differential scanning calorimetry. Dementia 3: 213–222
Gsell W, Conrad R, Hickethier M, Sofic E, Frolich L, Wichart I, Jellinger K, Moll G,
Ransmayr G, Beckmann H, et al. (1995) Decreased catalase activity but unchanged
superoxide dismutase activity in brains of patients with dementia of Alzheimer type.
J Neurochem 64: 1216–1223
Hajimohammadreza I, Brammer M (1990) Brain membrane fluidity and lipid peroxidation in Alzheimer's disease. Neurosci Lett 112: 333–337
Jobst KA, Smith AD, Szatmari M, Esiri MM, Jaskowski A, Hindley N, McDonald B,
Molyneux AJ (1994) Rapidly progressing atrophy of medial temporal lobe in
Alzheimer's disease. Lancet 343: 829–830
Kish SJ, Morito CL, Hornykiewicz O (1986) Brain glutathione peroxidase in
neurodegenerative disorders. Neurochem Pathol 4: 23–28
Kletzien RF, Harris PKW, Foellmi LI (1994) Glucose-6-phosphate dehydrogenase: a
“housekeeping” enzyme subject to tissue-specific regulation by hormones, nutrients
and oxidant stress. FASEB J 8: 174–181
Kosower N, Kosower E (1978) The glutathione status of cells. Int Rev Cytol 54: 109–
160
